Aragon Pharma Raises $22 Million
Aragon Pharmaceuticals Inc., a San Diego-based developer of treatments for hormonally-driven cancers, has raised $22 million in Series B funding. Aisling Capital was joined on the round by return backers OrbiMed Advisors and The Column Group.. Aragon previously raised around $8 million.
23 April 2010•3 mins read
